These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 29433016)
1. Self-sampling with HPV mRNA analyses from vagina and urine compared with cervical samples. Asciutto KC; Ernstson A; Forslund O; Borgfeldt C J Clin Virol; 2018 Apr; 101():69-73. PubMed ID: 29433016 [TBL] [Abstract][Full Text] [Related]
2. Comparison of urine, self-collected vaginal swab, and cervical swab samples for detecting human papillomavirus (HPV) with Roche Cobas HPV, Anyplex II HPV, and RealTime HR-S HPV assay. Cho HW; Ouh YT; Hong JH; Min KJ; So KA; Kim TJ; Paik ES; Lee JW; Moon JH; Lee JK J Virol Methods; 2019 Jul; 269():77-82. PubMed ID: 30998958 [TBL] [Abstract][Full Text] [Related]
3. Vaginal and Urine Self-sampling Compared to Cervical Sampling for HPV-testing with the Cobas 4800 HPV Test. Asciutto KC; Henningsson AJ; Borgfeldt H; Darlin L; Borgfeldt C Anticancer Res; 2017 Aug; 37(8):4183-4187. PubMed ID: 28739704 [TBL] [Abstract][Full Text] [Related]
4. Comparison of self-collected vaginal, vulvar and urine samples with physician-collected cervical samples for human papillomavirus testing to detect high-grade squamous intraepithelial lesions. Sellors JW; Lorincz AT; Mahony JB; Mielzynska I; Lytwyn A; Roth P; Howard M; Chong S; Daya D; Chapman W; Chernesky M CMAJ; 2000 Sep; 163(5):513-8. PubMed ID: 11006761 [TBL] [Abstract][Full Text] [Related]
5. VALHUDES: A protocol for validation of human papillomavirus assays and collection devices for HPV testing on self-samples and urine samples. Arbyn M; Peeters E; Benoy I; Vanden Broeck D; Bogers J; De Sutter P; Donders G; Tjalma W; Weyers S; Cuschieri K; Poljak M; Bonde J; Cocuzza C; Zhao FH; Van Keer S; Vorsters A J Clin Virol; 2018 Oct; 107():52-56. PubMed ID: 30195193 [TBL] [Abstract][Full Text] [Related]
6. Cobas 4800 HPV detection in the cervical, vaginal and urine samples of women with high-grade CIN before and after treatment. Stanczuk GA; Currie H; Baxter G; Foster A; Gibson L; Graham C; Cuschieri K J Clin Pathol; 2015 Jul; 68(7):567-70. PubMed ID: 25878328 [TBL] [Abstract][Full Text] [Related]
7. Increased HPV detection by the use of a pre-heating step on vaginal self-samples analysed by Aptima HPV assay. Borgfeldt C; Forslund O J Virol Methods; 2019 Aug; 270():18-20. PubMed ID: 31002831 [TBL] [Abstract][Full Text] [Related]
8. HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer. Wright TC; Denny L; Kuhn L; Pollack A; Lorincz A JAMA; 2000 Jan; 283(1):81-6. PubMed ID: 10632284 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of self-collected vaginal specimens for the detection of high-risk human papillomavirus infection and the prediction of high-grade cervical intraepithelial lesions in a high-burden, low-resource setting. Toliman PJ; Kaldor JM; Badman SG; Phillips S; Tan G; Brotherton JML; Saville M; Vallely AJ; Tabrizi SN Clin Microbiol Infect; 2019 Apr; 25(4):496-503. PubMed ID: 29906593 [TBL] [Abstract][Full Text] [Related]
10. Clinical validation of hrHPV testing on vaginal and urine self-samples in primary cervical screening (cross-sectional results from the Papillomavirus Dumfries and Galloway-PaVDaG study). Stanczuk G; Baxter G; Currie H; Lawrence J; Cuschieri K; Wilson A; Arbyn M BMJ Open; 2016 Apr; 6(4):e010660. PubMed ID: 27113237 [TBL] [Abstract][Full Text] [Related]
11. [HPV E6 and E7 mRNA combined with HPV 16 and 18 or 45 genotyping testing as a means of cervical cancer opportunistic screening]. Wang JJ; Dong J; Deng ZX; Wang PF; Zhang XX; Du Y Zhonghua Fu Chan Ke Za Zhi; 2019 May; 54(5):301-306. PubMed ID: 31154710 [No Abstract] [Full Text] [Related]
12. Are vaginal swabs comparable to cervical smears for human papillomavirus DNA testing? Coorevits L; Traen A; Bingé L; Van Dorpe J; Praet M; Boelens J; Padalko E J Gynecol Oncol; 2018 Jan; 29(1):e8. PubMed ID: 29185266 [TBL] [Abstract][Full Text] [Related]
13. Comparison of vaginal self-sampling and cervical sampling by medical professionals for the detection of HPV and CIN2+: A randomized study. Aarnio R; Isacson I; Sanner K; Gustavsson I; Gyllensten U; Olovsson M Int J Cancer; 2021 Jun; 148(12):3051-3059. PubMed ID: 33497465 [TBL] [Abstract][Full Text] [Related]
14. Performance and Diagnostic Accuracy of Human Papillomavirus Testing on Self-Collected Urine and Vaginal Samples in a Referral Population. Cho HW; Hong JH; Min KJ; Ouh YT; Seong SJ; Moon JH; Cho SH; Lee JK Cancer Res Treat; 2021 Jul; 53(3):829-836. PubMed ID: 33421987 [TBL] [Abstract][Full Text] [Related]
15. High-risk human papillomavirus messenger RNA testing in physician- and self-collected specimens for cervical lesion detection in high-risk women, Kenya. Ting J; Mugo N; Kwatampora J; Hill C; Chitwa M; Patel S; Gakure H; Kimani J; Schoenbach VJ; Poole C; Smith JS Sex Transm Dis; 2013 Jul; 40(7):584-9. PubMed ID: 23965776 [TBL] [Abstract][Full Text] [Related]
16. Predictive Value of HPV Testing in Self-collected and Clinician-Collected Samples Compared with Cytology in Detecting High-grade Cervical Lesions. El-Zein M; Bouten S; Louvanto K; Gilbert L; Gotlieb WH; Hemmings R; Behr MA; Franco EL; Cancer Epidemiol Biomarkers Prev; 2019 Jul; 28(7):1134-1140. PubMed ID: 31015201 [TBL] [Abstract][Full Text] [Related]
17. A prospective double-blind cross-sectional study of the accuracy of the use of dry vaginal tampons for self-sampling of human papillomaviruses. Khan AM; Sasieni P; Singer A BJOG; 2015 Feb; 122(3):388-94. PubMed ID: 25088393 [TBL] [Abstract][Full Text] [Related]
18. Clinical Performance of Self-collected Specimen HPV-DNA vs Clinician- collected Specimen HPV-mRNA to Detect High-risk HPV and High-grade Cervical Lesions and Cancer. Kittisiam T; Chanpanitkitchot S; Tangjitgamol S; Srijaipracharoen S; Manusirivithaya S; Srisomboon J; Termrungruanglert W Asian Pac J Cancer Prev; 2024 Jan; 25(1):211-217. PubMed ID: 38285786 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of a new APTIMA specimen collection and transportation kit for high-risk human papillomavirus E6/E7 messenger RNA in cervical and vaginal samples. Chernesky M; Jang D; Gilchrist J; Elit L; Lytwyn A; Smieja M; Dockter J; Getman D; Reid J; Hill C Sex Transm Dis; 2014 Jun; 41(6):365-8. PubMed ID: 24825332 [TBL] [Abstract][Full Text] [Related]
20. Urine collection in cervical cancer screening - analytical comparison of two HPV DNA assays. Tranberg M; Jensen JS; Bech BH; Andersen B BMC Infect Dis; 2020 Dec; 20(1):926. PubMed ID: 33276740 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]